Business mix
- Research models and services: animal models, model services, and early research tools.
- Discovery and safety assessment: discovery support, toxicology, and non-clinical development services.
- Manufacturing support: biologics testing, microbial testing, and quality-control services.
Current key questions
- When do biotech funding, pharma budgets, and customer inventory normalization improve order trends?
- Can safety-assessment utilization and pricing recover enough to restore margins?
- How do regulation, model demand, and acquisition integration affect long-term growth?
